Skip to main content
William Wilcox, MD, Medical Genetics, Atlanta, GA, Children's Healthcare of Atlanta

WilliamWilcoxMDPhD

Medical Genetics Atlanta, GA

Clinical Biochemical Genetics, Clinical Genetics, Clinical Molecular Genetics

Professor of Human Genetics, Emory University

Dr. Wilcox is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wilcox's full profile

Already have an account?

Education & Training

  • Intercampus Medical Genetics Training Program
    Intercampus Medical Genetics Training ProgramN/A, 1991 - 1994
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1989 - 1991
  • Molecular Biology, UCLA
    Molecular Biology, UCLAPh.D, 1989 - 1989
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Pediatrics, 1988 - 1989
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1988
  • Biochemistry and Mathematics, UCLA
    Biochemistry and Mathematics, UCLABS, 1982 - 1982

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2013 - 2023
  • CA State Medical License
    CA State Medical License 1989 - 2023
  • MS State Medical License
    MS State Medical License 1969 - 2017
  • American Board of Medical Genetics and Genomics Clinical Molecular Genetics and Genomics

Awards, Honors, & Recognition

  • John M. Adams award for excellence in Pediatrics 1988
  • UCLA Alumni Scholar, 1977-1982 1982
  • Phi Beta Kappa 1982
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a lys650met mutation in fi...  
    Bellus, G.A., Bamshad, M.J., Przylepa, K., Dorst, J., Lee, R., Hurko, O., Jabs, E.W., Curry, C.J.R., Wilcox, W.R., Lachman, R.S., Rimoin, D.L., Francomano, C.A, Am. J. Med. Genet. 85:53-65
  • Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hunermann syndrome.  
    Braverman, N., Lin, P., Moebius, F.F., Obie, C., Moser, A., Glossman, H., Wilcox, W.R., Rimoin, D.L., Smith, M., Kratz, L., Kelley, R.I., Valle, D, Nat. Genet. 22:291-294
  • Small deletions in the type II collagen triple helix produce Kniest dysplasia.  
    Wilkin, D.J., Artz, A.S., South, S., Lachman, R.S., Rimoin, D.L., Wilcox, W.R., McKusick, V.A., Stratakis, C.A., Francomano, C.A., Cohn, D.H, Am. J. Med. Genet. 85:105-112
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Molecular, radiographic and histopathologic correlations in thanatophoric dysplasia.
    Wilcox, W., Tavormina, P., Krakow, D., Lachman, R., Wasmuth, J., Thompson, L., and Rimoin, D, International Skeletal Dysplasia Meeting, Marina Del Rey
  • Cummings syndrome: report of 2 additional cases.
    Dibbern, K., Graham, J., Lachman, R., Rimoin, D., Wilcox, W, 3rd International Skeletal Dysplasia Meeting, Marina Del Rey
  • Platyspondylic lethal skeletal dysplasia with secondary pelvic ossification centers: a subtype of the San Diego variant or a distinct entity?
    Kitoh, H., Lachman, R., Rimoin, D., Wilcox, W, 3rd International Skeletal Dysplasia Meeting, Marina Del Rey
  • Join now to see all

Lectures

  • David Smith Conference On Dysmorphology. 
    Greenwood
  • Bone Dysplasia Society. 
    Versailles
  • Western Society for Pediatric Research. 
    Carmel
  • Join now to see all

Press Mentions

  • Emory Advances Care for People with Rare Diseases
    Emory Advances Care for People with Rare DiseasesFebruary 25th, 2022

Grant Support

  • Clinical Trial: A 12-Week Study To Evaluate The Safety Of At1001 In Patients WitNational Center For Research Resources2008
  • A 12-Week Study To Evaluate The Safety Of At1001 In Patients With Fabry DiseaseNational Center For Research Resources2007
  • Multi-Center, OPEN Label Study Of The Safety And Efficacy Of FabrazymeNational Center For Research Resources2006
  • Multi-Center, OPEN Label Study Of The Safety And Efficacy Of Fabrazyme In PatienNational Center For Research Resources2005
  • A Multicenter, OPEN Label Extension Study Agalactosidase A (R-Hagal)National Center For Research Resources2005
  • A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study Of The SafetyNational Center For Research Resources2005
  • Trial Of Antiresporptive Therapy For Osteopenia In Pediatric Gaucher PatientsNational Center For Research Resources2004
  • Trial Of Antiresorptive Therapy For Osteopenia In Pediatric Gaucher PatientsNational Center For Research Resources2004
  • Multicenter, OPEN Label Extension Study ...A-GalactosidNational Center For Research Resources2004
  • Multi-Center, Randomized, Double-Blind, Placebo ControNational Center For Research Resources2004
  • Effect Of FGFR3 Gene Mutation On Linear Bone GrowthNational Center For Research Resources1999–2001
  • Safety &Efficacy Of Rhagal Replacement In Patients With Fabry'S DiseaseNational Center For Research Resources2000
  • Collagen Stability In Osteogenesis ImperfectaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1993

Hospital Affiliations